ARYx is a pharmaceutical company focused on retrometabolic drug designing and improving the safety of oral therapies for chronic diseases.
Business Model:
Revenue: $10M
Employees: 2-10
Address:
City: Fremont
State: California
Zip:
Country: United States
ARYx is a product-driven pharmaceutical company with leading expertise and significant intellectual property in the area of retrometabolic drug design. They are focused on improving the safety of oral therapies for chronic disease.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2008 | Post-IPO Equity | 3 | $21.6M |
MPM Capital New Enterprise Associates OrbiMed MPM Capital New Enterprise Associates OrbiMed |
2/2006 | Series E | 3 | $30.4M |
Ascent Biomedical Ventures MPM Capital Phase4 Ventures Ascent Biomedical Ventures MPM Capital Phase4 Ventures |
7/2002 | Series C | 3 | $25M |
Merlin Biomed MPM Capital OrbiMed Merlin Biomed MPM Capital OrbiMed |
6/2004 | Series D | 10 | $55M |
ATEL Ventures ITOCHU Technology Ventures Jafco Life Science Merlin Biomed Montreux Equity Partners MPM Capital Novel Bioventures OrbiMed Phase4 Ventures Scottish Widows Investment Partnership ATEL Ventures ITOCHU Technology Ventures Jafco Life Science Merlin Biomed Montreux Equity Partners MPM Capital Novel Bioventures OrbiMed Phase4 Ventures Scottish Widows Investment Partnership |
8/2010 | Post-IPO Debt | 1 | $6.3M |
Lighthouse Capital Partners Lighthouse Capital Partners |
11/2009 | Post-IPO Equity | $357.4k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|